Publications

1. Kearns AE. OSTEOPOROSIS SECONDARY FRACTURE PREVENTION: A UNITED VOICE. Endocr Pract. 2020 May; 26 (5):571-572
   View PubMed
2. Conley RB, Adib G, Adler RA, Akesson KE, Alexander IM, Amenta KC, Blank RD, Brox WT, Carmody EE, Chapman-Novakofski K, Clarke BL, Cody KM, Cooper C, Crandall CJ, Dirschl DR, Eagen TJ, Elderkin AL, Fujita M, Greenspan SL, Halbout P, Hochberg MC, Javaid M, Jeray KJ, Kearns AE, King T, Koinis TF, Koontz JS, Kuzma M, Lindsey C, Lorentzon M, Lyritis GP, Michaud LB, Miciano A, Morin SN, Mujahid N, Napoli N, Olenginski TP, Puzas JE, Rizou S, Rosen CJ, Saag K, Thompson E, Tosi LL, Tracer H, Khosla S, Kiel DP. Secondary Fracture Prevention: Consensus Clinical Recommendations From a Multistakeholder Coalition. Orthop Nurs. 2020 May/Jun; 39 (3):145-161
   View PubMed
3. Conley RB, Adib G, Adler RA, Akesson KE, Alexander IM, Amenta KC, Blank RD, Brox WT, Carmody EE, Chapman-Novakofski K, Clarke BL, Cody KM, Cooper C, Crandall CJ, Dirschl DR, Eagen TJ, Elderkin AL, Fujita M, Greenspan SL, Halbout P, Hochberg MC, Javaid M, Jeray KJ, Kearns AE, King T, Koinis TF, Koontz JS, Kuzma M, Lindsey C, Lorentzon M, Lyritis GP, Michaud LB, Miciano A, Morin SN, Mujahid N, Napoli N, Olenginski TP, Puzas JE, Rizou S, Rosen CJ, Saag K, Thompson E, Tosi LL, Tracer H, Khosla S, Kiel DP. Secondary Fracture Prevention: Consensus Clinical Recommendations from a Multistakeholder Coalition. J Orthop Trauma. 2020 Apr; 34 (4):e125-e141
   View PubMed
4. Conley RB, Adib G, Adler RA, Akesson KE, Alexander IM, Amenta KC, Blank RD, Brox WT, Carmody EE, Chapman-Novakofski K, Clarke BL, Cody KM, Cooper C, Crandall CJ, Dirschl DR, Eagen TJ, Elderkin AL, Fujita M, Greenspan SL, Halbout P, Hochberg MC, Javaid M, Jeray KJ, Kearns AE, King T, Koinis TF, Koontz JS, Kuzma M, Lindsey C, Lorentzon M, Lyritis GP, Michaud LB, Miciano A, Morin SN, Mujahid N, Napoli N, Olenginski TP, Puzas JE, Rizou S, Rosen CJ, Saag K, Thompson E, Tosi LL, Tracer H, Khosla S, Kiel DP. Secondary Fracture Prevention: Consensus Clinical Recommendations from a Multistakeholder Coalition. J Bone Miner Res. 2020 Jan; 35 (1):36-52 Epub 2019 Dec 01
   View PubMed
5. Jayawardena E, Li D, Nakanishi R, Dey D, Dailing C, Qureshi A, Dickens B, Hathiramani N, Kim M, Flores F, Kearns AE, Lui LY, Black D, Budoff MJ. Non-contrast cardiac CT-based quantitative evaluation of epicardial and intra-thoracic fat in healthy, recently menopausal women: Reproducibility data from the Kronos Early Estrogen Prevention Study. J Cardiovasc Comput Tomogr. 2020 Jan - Feb; 14 (1):55-59 Epub 2019 May 04
   View PubMed
6. Kearns AE, Espiritu RP, Vickers Douglass K, Thapa P, Wermers RA. Clinical characteristics and depression score response after parathyroidectomy in primary hyperparathyroidism. Clin Endocrinol (Oxf). 2019 Sep; 91 (3):464-470 Epub 2019 June 25
   View PubMed
7. El Khoudary SR, Zhao Q, Venugopal V, Manson JE, Brooks MM, Santoro N, Black DM, Harman SM, Cedars MI, Hopkins PN, Kearns AE, Miller VM, Taylor HS, Budoff MJ. Effects of Hormone Therapy on Heart Fat and Coronary Artery Calcification Progression: Secondary Analysis From the KEEPS Trial. J Am Heart Assoc. 2019 Aug 6; 8 (15):e012763 Epub 2019 Aug 01
   View PubMed
8. Beckman JP, Camp JJ, Lahr BD, Bailey KR, Kearns AE, Garovic VD, Jayachandran M, Miller VM, Holmes DR 3rd. Pregnancy history, coronary artery calcification and bone mineral density in menopausal women. Climacteric. 2018 Feb; 21 (1):53-59 Epub 2017 Nov 30
   View PubMed
9. James H, Holte P, Kearns AE. Improving Vitamin D Deficiency Identification/Treatment in Hip Fracture Patients The Journal of Nurse Practitioners. 2016; 12(9):e385-e388.
   
10. Griebeler ML, Kearns AE, Ryu E, Thapa P, Hathcock MA, Melton LJ 3rd, Wermers RA. Thiazide-Associated Hypercalcemia: Incidence and Association With Primary Hyperparathyroidism Over Two Decades. J Clin Endocrinol Metab. 2016 Mar; 101 (3):1166-73 Epub 2016 Jan 11
    View PubMed
11. Natt N, Chang AY, Berbari EF, Kennel KA, Kearns AE. SELECTION OF ENDOCRINOLOGY SUBSPECIALTY TRAINEES: WHICH APPLICANT CHARACTERISTICS ARE ASSOCIATED WITH PERFORMANCE DURING FELLOWSHIP TRAINING? Endocr Pract. 2016 Jan; 22: (1)45-50.
    View PubMed
12. Wagner-Johnston ND, Sloan JA, Liu H, Kearns AE, Hines SL, Puttabasavaiah S, Dakhil SR, Lafky JM, Perez EA, Loprinzi CL. 5-year follow-up of a randomized controlled trial of immediate versus delayed zoledronic acid for the prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen: N03CC (Alliance) trial. Cancer. 2015 Aug 1; 121 (15):2537-43 Epub 2015 Apr 30
    View PubMed
13. Griebeler ML, Kearns AE, Ryu E, Hathcock MA, Melton LJ 3rd, Wermers RA. Secular trends in the incidence of primary hyperparathyroidism over five decades (1965-2010). Bone. 2015 Apr; 73:1-7 Epub 2014 Dec 11
    View PubMed
14. Sarfani S, Scrabeck T, Kearns AE, Berger RA, Kakar S. Clinical efficacy of a fragility care program in distal radius fracture patients. J Hand Surg Am. 2014 Apr; 39(4):664-9. Epub 2014 Feb 25.
    View PubMed
15. Farr JN, Khosla S, Miyabara Y, Miller VM, Kearns AE. Effects of estrogen with micronized progesterone on cortical and trabecular bone mass and microstructure in recently postmenopausal women. J Clin Endocrinol Metab. 2013 Feb; 98 (2):E249-57 Epub 2013 Jan 15
    View PubMed
16. Dy BM, Grant CS, Wermers RA, Kearns AE, Huebner M, Harmsen WS, Thompson GB, Farley DR, Richards ML. Changes in bone mineral density after surgical intervention for primary hyperparathyroidism. Surgery. 2012 Dec; 152(6):1051-8. Epub 2012 Oct 03.
    View PubMed
17. Miyabara Y, Holmes D 3rd, Camp J, Miller VM, Kearns AE. Comparison of calibrated and uncalibrated bone mineral density by CT to DEXA in menopausal women. Climacteric. 2012 Aug; 15 (4):374-81 Epub 2011 Dec 17
    View PubMed
18. Espiritu RP, Kearns AE, Vickers KS, Grant C, Ryu E, Wermers RA. Depression in primary hyperparathyroidism: prevalence and benefit of surgery. J Clin Endocrinol Metab. 2011 Nov; 96(11):E1737-45. Epub 2011 Sep 14.
    View PubMed
19. Miyabara Y, Camp J, Holmes D 3rd, Lahr B, Bailey K, Miller VM, Kearns AE. Coronary arterial calcification and thoracic spine mineral density in early menopause. Climacteric. 2011 Aug; 14(4):438-44. Epub 2011 Jan 25.
    View PubMed
20. Davidge Pitts CJ, Kearns AE. Update on medications with adverse skeletal effects. Mayo Clin Proc. 2011 Apr; 86 (4):338-43; quiz 343 Epub 2011 Mar 09
    View PubMed
21. Seeman E, Delmas PD, Hanley DA, Sellmeyer D, Cheung AM, Shane E, Kearns A, Thomas T, Boyd SK, Boutroy S, Bogado C, Majumdar S, Fan M, Libanati C, Zanchetta J. Microarchitectural deterioration of cortical and trabecular bone: differing effects of denosumab and alendronate. J Bone Miner Res. 2010 Aug; 25(8):1886-94.
    View PubMed
22. Kearns AE, Northfelt DW, Dueck AC, Atherton PJ, Dakhil SR, Rowland KM Jr, Fuloria J, Flynn PJ, Dentchev T, Loprinzi CL. Osteoporosis prevention in prostate cancer patients receiving androgen ablation therapy: placebo-controlled double-blind study of estradiol and risedronate: N01C8. Support Care Cancer. 2010 Mar; 18 (3):321-8 Epub 2009 May 27
    View PubMed
23. Melton LJ 3rd, Kearns AE, Atkinson EJ, Bolander ME, Achenbach SJ, Huddleston JM, Therneau TM, Leibson CL. Secular trends in hip fracture incidence and recurrence. Osteoporos Int. 2009 May; 20 (5):687-94 Epub 2008 Sept 17
    View PubMed
24. Kearns AE, Kallmes DF. Osteoporosis primer for the vertebroplasty practitioner: expanding the focus beyond needles and cement. AJNR Am J Neuroradiol. 2008 Nov; 29: (10)1816-22.
    View PubMed
25. Chow JT, Khosla S, Melton LJ 3rd, Atkinson EJ, Camp JJ, Kearns AE. Abdominal aortic calcification, BMD, and bone microstructure: a population-based study. J Bone Miner Res. 2008 Oct; 23 (10):1601-12
    View PubMed
26. Kearns AE, Khosla S, Kostenuik PJ. Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease. Endocr Rev. 2008 Apr; 29 (2):155-92 Epub 2007 Dec 05
    View PubMed
27. Wermers RA, Kearns AE, Jenkins GD, Melton LJ 3rd. Incidence and clinical spectrum of thiazide-associated hypercalcemia. Am J Med. 2007 Oct; 120 (10):911.e9-15 Epub 2007 Apr 16
    View PubMed
28. Hallanger Johnson JE, Kearns AE, Doran PM, Khoo TK, Wermers RA. Fluoride-related bone disease associated with habitual tea consumption. Mayo Clin Proc. 2007 Jun; 82 (6):719-24
    View PubMed
29. From AM, Hyder JA, Kearns AM, Bailey KR, Pellikka PA. Relationship between low bone mineral density and exercise-induced myocardial ischemia. Mayo Clin Proc. 2007 Jun; 82 (6):679-85
    View PubMed
30. Wermers RA, Hurley DL, Kearns AE. Osteoporosis associated with megestrol acetate. Mayo Clin Proc. 2004 Dec; 79(12):1557-61.
    View PubMed
31. Kearns AE. Primary hyperparathyroidism: is there anything new? Compr Ther. 2004 Summer; 30 (2):105-10
    View PubMed
32. Kearns AE, Khosla S. Potential anabolic effects of androgens on bone. Mayo Clin Proc. 2004 Apr; 79 (4 Suppl):S14-8
    View PubMed
33. Modder UI, Sanyal A, Kearns AE, Sibonga JD, Nishihara E, Xu J, O'Malley BW, Ritman EL, Riggs BL, Spelsberg TC, Khosla S. Effects of loss of steroid receptor coactivator-1 on the skeletal response to estrogen in mice. Endocrinology. 2004 Feb; 145: (2)913-21.
    View PubMed
34. Kearns AE, Thompson GB. Medical and surgical management of hyperparathyroidism. Mayo Clin Proc. 2002 Jan; 77(1):87-91.
    View PubMed
35. Kearns AE, Donohue MM, Sanyal B, Demay MB. Cloning and characterization of a novel protein kinase that impairs osteoblast differentiation in vitro. J Biol Chem. 2001 Nov 9; 276(45):42213-8. Epub 2001 Aug 10.
    View PubMed
36. Kearns AE, Demay MB. BMP-2 induces expression of activin BA and fillistatin in vitro. J Cell Biochem,. 2000; 79: 80-8.
    
37. Kearns AE, Goff DC, Hayden DL, Daniels GH. Risperidone-associated hyperprolactinemina. Endo Practice,. 2000; 6: 425-9.
    
38. Kearns AE, Goto K, Gianakakos G, Lippmann W, Demay MB. Transcriptional repression of the rat osteocalcin gene: role of two intronic CCTCCT motifs. Endocrinology. 1999 Sep; 140(9):4120-6.
    View PubMed
39. Vertel BM, Walters LM, Flay N, Kearns AE, Schwartz NB. Xylosylation is an endoplasmic reticulum to Golgi event. J Biol Chem. 1993 May 25; 268(15):11105-12.
    View PubMed
40. Kearns AE, Vertel BM, Schwartz NB. Topography of glycosylation and UDP-xylose production. J Biol Chem. 1993 May 25; 268(15):11097-104.
    View PubMed
41. Ng K, D'Souza M, Callahan L, Geller DH, Kearns AE, Lyle S, Schwartz NB. Synthesis and utilization of a nonhydrolyzable phosphoadenosine phosphosulfate analog. Anal Biochem. 1991 Oct; 198(1):60-7.
    View PubMed
42. Kearns AE, Campbell SC, Westley J, Schwartz NB. Initiation of chondroitin sulfate biosynthesis: a kinetic analysis of UDP-D-xylose: core protein beta-D-xylosyltransferase. Biochemistry. 1991 Jul 30; 30(30):7477-83.
    View PubMed